The Effects of Agomelatine Treatment on Lipopolysaccharide-Induced Septic Lung Injuries in Rats
dc.authorscopusid | 56779839000 | |
dc.authorscopusid | 55367802000 | |
dc.authorscopusid | 6508093438 | |
dc.authorscopusid | 16174252200 | |
dc.authorscopusid | 57218420772 | |
dc.authorwosid | Gurbuz, Muhammet Ali/AAA-4948-2022 | |
dc.contributor.author | Köse, Duygu | |
dc.contributor.author | Yüksel, Tuğba Nurcan | |
dc.contributor.author | Halıcı, Zekai | |
dc.contributor.author | Çadırcı, Elif | |
dc.contributor.author | Gürbüz, Muhammed Ali | |
dc.date.accessioned | 2022-05-11T14:41:12Z | |
dc.date.available | 2022-05-11T14:41:12Z | |
dc.date.issued | 2021 | |
dc.department | Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Tıbbi Farmakoloji Ana Bilim Dalı | |
dc.description.abstract | Objective: We designed an experimental model of sepsis in rats to investigate the effects of agomelatine (AGO) on lung tissues using molecular and histopathological methods. Materials and Methods: In our experimental model, the 32 rats were divided into 4 groups: group 1: control group (HEALTHY); group 2: lipopolysaccharide group (LPS); group 3: LPS plus 50 mg/kg AGO group (LPS + AGO50); and group 4: LPS plus 100 mg/kg AGO group (LPS + AGO100). An LPS-induced sepsis model was performed to replicate the pathology of sepsis. Rats from all 4 groups were killed after 12 hours, and their lungs were quickly collected. To investigate the therapeutic strategy, we evaluated tumor necrosis factoralpha (TNF-alpha) and nuclear factor-kappa B (NF-kappa B) messenger RNA expressions by real-time polymerase chain reaction using molecular methods and lung tissue damage indicators using histopathological methods. Results: The expressions of TNF-alpha and NF-kappa B were reduced in the groups treated with AGO. The histopathology results supported the molecular results. Conclusion: In this experimental study, we demonstrated for the first time the positive effects of AGO on LPS-induced sepsis in lung tissue using molecular and histopathological methods, indicating that it contributes to the prevention of lung damage. | |
dc.identifier.doi | 10.5152/eurasianjmed.2021.20342 | |
dc.identifier.endpage | 131 | |
dc.identifier.issn | 1308-8742 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 34177296 | |
dc.identifier.scopus | 2-s2.0-85108508720 | |
dc.identifier.scopusquality | Q3 | |
dc.identifier.startpage | 127 | |
dc.identifier.uri | https://doi.org/10.5152/eurasianjmed.2021.20342 | |
dc.identifier.uri | https://hdl.handle.net/20.500.11776/9106 | |
dc.identifier.volume | 53 | |
dc.identifier.wos | WOS:000660311100011 | |
dc.identifier.wosquality | N/A | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.institutionauthor | Yüksel, Tuğba Nurcan | |
dc.language.iso | en | |
dc.publisher | Aves | |
dc.relation.ispartof | Eurasian Journal of Medicine | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Sepsis | |
dc.subject | agomelatine | |
dc.subject | tumor necrosis factor-alpha | |
dc.subject | nuclear factor-kappa B | |
dc.subject | Melatonin Receptor | |
dc.subject | Animal-Models | |
dc.subject | Mt2 Receptors | |
dc.subject | Sepsis | |
dc.subject | Genes | |
dc.title | The Effects of Agomelatine Treatment on Lipopolysaccharide-Induced Septic Lung Injuries in Rats | |
dc.type | Article |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- 9106.pdf
- Boyut:
- 614.04 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text